메뉴 건너뛰기
American Journal of Gastroenterology
Volumn 96, Issue 5, 2001, Pages 1663-1665
Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis [20]
Author keywords

[No Author keywords available]
Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; DICLOFENAC; MISOPROSTOL; NAPROXEN; OMEPRAZOLE; PROSTAGLANDIN; ROFECOXIB;
EID: 0035017037     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2001.03835.x     Document Type: Letter
Times cited : (10)
References (8)
  • 1
    • 0034041077 scopus 로고    scopus 로고
    • Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
    • L.J. Crofford P. Lipsky P. Brooks Basic biology and clinical application of specific cyclooxygenase-2 inhibitors Arthritis Rheum 43 2000 4 13
    • (2000) Arthritis Rheum , vol.43 , pp. 4-13
    • Crofford, L.J.1    Lipsky, P.2    Brooks, P.3
  • 2
    • 0033031331 scopus 로고    scopus 로고
    • COX-2 inhibitors
    • C.J. Hawekey COX-2 inhibitors Lancet 353 1999 307 314
    • (1999) Lancet , vol.353 , pp. 307-314
    • Hawekey, C.J.1
  • 3
    • 0033971402 scopus 로고    scopus 로고
    • Do cyclooxygenase inhibitors provide benefits similar those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    • M. Feldman A. McMahon Do cyclooxygenase inhibitors provide benefits similar those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 132 2000 134 143
    • (2000) Ann Intern Med , vol.132 , pp. 134-143
    • Feldman, M.1    McMahon, A.2
  • 4
    • 0033930616 scopus 로고    scopus 로고
    • Reduced risk of upper gastrointestinal ulcer complication with Celecoxib, a novel COX-2 inhibitor
    • J.L. Goldstein F.E. Silverstein N.M. Agrawal Reduced risk of upper gastrointestinal ulcer complication with Celecoxib, a novel COX-2 inhibitor Am J Gastroenterol 95 2000 1681 1690
    • (2000) Am J Gastroenterol , vol.95 , pp. 1681-1690
    • Goldstein, J.L.1    Silverstein, F.E.2    Agrawal, N.M.3
  • 5
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with Celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthitis and rheumatoid arthritis. The CLASS study: A randomized controlled trial
    • F.E. Silverstein G. Faich J.L. Goldstein Gastrointestinal toxicity with Celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthitis and rheumatoid arthritis. The CLASS study A randomized controlled trial JAMA 284 2000 1247 1255
    • (2000) JAMA , vol.284 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 6
    • 0033601079 scopus 로고    scopus 로고
    • Adverse upper gastrointestinal effects of Rofecoxib compared with NSAIDs
    • M. Langman D.M. Jensen D.J. Watson Adverse upper gastrointestinal effects of Rofecoxib compared with NSAIDs JAMA 282 1999 1929 1933
    • (1999) JAMA , vol.282 , pp. 1929-1933
    • Langman, M.1    Jensen, D.M.2    Watson, D.J.3
  • 7
    • 0034707105 scopus 로고    scopus 로고
    • Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patient with rheumatoid arthritis
    • C. Bombardier L. Laine A. Reicin Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patient with rheumatoid arthritis N Engl J Med 343 2000 1520 1528
    • (2000) N Engl J Med , vol.343 , pp. 1520-1528
    • Bombardier, C.1    Laine, L.2    Reicin, A.3
  • 8
    • 0032468069 scopus 로고    scopus 로고
    • A guideline for the treatment and prevention of NSAID-induced ulcers
    • F.L. Lanza A guideline for the treatment and prevention of NSAID-induced ulcers Am J Gastroenterol 93 1998 2037 2047
    • (1998) Am J Gastroenterol , vol.93 , pp. 2037-2047
    • Lanza, F.L.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.